| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/13/2000 | CA2346019A1 Use of catechol derivatives as proteinase inhibitors |
| 04/13/2000 | CA2345997A1 Benzamide derivatives as thrombin inhibitors |
| 04/13/2000 | CA2345642A1 Methods for the treatment of non-thyroid disorders |
| 04/13/2000 | CA2345577A1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 04/13/2000 | CA2345408A1 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 04/13/2000 | CA2345209A1 Antisense modulation of integrin .alpha.4 expression |
| 04/13/2000 | CA2345137A1 Mglur5 antagonists for the treatment of pain and anxiety |
| 04/13/2000 | CA2345110A1 Reduction of oxidative stress factors |
| 04/13/2000 | CA2345045A1 G-protein coupled receptor proteins |
| 04/13/2000 | CA2345023A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | CA2344973A1 Oxidoreductase molecules |
| 04/13/2000 | CA2344807A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | CA2344613A1 Compositions and methods for inhibiting angiogenesis |
| 04/13/2000 | CA2344551A1 P-conotoxin peptide |
| 04/13/2000 | CA2335391A1 Akt compositions for enhancing survival of cells |
| 04/12/2000 | EP0992510A1 N6 heterocyclic substituted adenosine derivatives |
| 04/12/2000 | EP0992496A1 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors |
| 04/12/2000 | EP0992495A1 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride |
| 04/12/2000 | EP0992493A1 Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists |
| 04/12/2000 | EP0992492A1 Small molecule inhibitors of rotamase enzyme activity |
| 04/12/2000 | EP0991759A1 Ntn-2 member of tnf ligand family |
| 04/12/2000 | EP0991758A1 Smad6 and uses thereof |
| 04/12/2000 | EP0991753A1 Protease inhibitors |
| 04/12/2000 | EP0991670A1 Method for fixing or separating ions, in particular of lead, using per(3,6-anhydro) cyclodextrin derivatives |
| 04/12/2000 | EP0991666A1 Alpha 1-antitrypsin preparation and method for the production thereof |
| 04/12/2000 | EP0991665A1 Peptides and compounds that bind to the il-5 receptor |
| 04/12/2000 | EP0991659A1 Peptides and compounds that bind to the il-5 receptor |
| 04/12/2000 | EP0991654A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/12/2000 | EP0991653A1 Novel compounds |
| 04/12/2000 | EP0991652A1 Tricyclic pyrazolo-pyridazinone analogues as gaba-a receptor ligands |
| 04/12/2000 | EP0991650A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
| 04/12/2000 | EP0991647A1 Eprosartan monohydrate |
| 04/12/2000 | EP0991644A1 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors |
| 04/12/2000 | EP0991643A1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 04/12/2000 | EP0991642A1 2-aminoalkylaminoquinolines as dopamine d4 ligands |
| 04/12/2000 | EP0991639A1 4- (1h-imidazol-4-yl)piperidin-1-yl]anilide derivatives, their preparation and application in therapy |
| 04/12/2000 | EP0991637A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors |
| 04/12/2000 | EP0991636A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 04/12/2000 | EP0991632A1 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| 04/12/2000 | EP0991630A1 Crystalline roxifiban |
| 04/12/2000 | EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES |
| 04/12/2000 | EP0991627A1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/12/2000 | EP0991626A2 Pyrimidin-2,4,6-trion derivatives, method for producing the same and medicinal products containing these compounds |
| 04/12/2000 | EP0991624A1 Phenylalkyl derivatives with thrombin-inhibiting effect |
| 04/12/2000 | EP0991622A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 04/12/2000 | EP0991616A1 METHOD FOR PRODUCING MEDICAMENTS CONTAINING HMG-CoA-REDUCTASE INHIBITORS |
| 04/12/2000 | EP0991426A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 04/12/2000 | EP0991425A1 Pro |
| 04/12/2000 | EP0991422A1 Modulating epithelial-mesenchymal interactions |
| 04/12/2000 | EP0991410A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates |
| 04/12/2000 | EP0991406A1 Il-8 receptor antagonists |
| 04/12/2000 | EP0810829B1 Amino acid compositions and use thereof in clinical nutrition |
| 04/12/2000 | EP0794951B1 Processes and intermediates for preparing cis (+) 3-[4,6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
| 04/12/2000 | EP0707566B1 Novel structural analogues of vitamin d |
| 04/12/2000 | EP0621270B1 Piperazine derivatives as collagenase inhibitors |
| 04/12/2000 | CN1250445A Sulfamide-metalloprotease inhibitors |
| 04/12/2000 | CN1250444A 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (D4) |
| 04/12/2000 | CN1250380A Bovine respiratory and enteric coronavirus as a vaccine |
| 04/12/2000 | CN1250375A Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 04/12/2000 | CN1250373A Composition and method for suppelmenting testosterone in women with symptoms of testosterone deficiency |
| 04/12/2000 | CN1250051A New indane-1-alcohol compound, its preparation method and medical composition containing the same |
| 04/12/2000 | CN1249936A Health food capable of returning youthful vigour |
| 04/12/2000 | CN1249932A New application of Modafenyl and its optical antimer1 and isomer-d |
| 04/12/2000 | CN1051313C 5-arylindole derivatives and its use, pharmaceutical composition containing the same and intermediate for preparing them |
| 04/12/2000 | CN1051311C N-heteroaryl-n'-phenylurea derivatives, their production and use |
| 04/12/2000 | CN1051302C 3-(indol-3-yL) propenoic acid derivatives and as NMDA antagonists |
| 04/12/2000 | CN1051228C Novel medical composition containing hyaluronic acid associates and its preparing process |
| 04/11/2000 | US6048965 Polypeptide that controls the premature degradation of transcripts |
| 04/11/2000 | US6048964 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 04/11/2000 | US6048898 Synthesis of glatiramer acetate (copolymer-1) |
| 04/11/2000 | US6048896 For treatment of brain or nervous system disorders |
| 04/11/2000 | US6048895 Antagonists of prostaglandin f for treating bone fractures and diseases and glaucoma |
| 04/11/2000 | US6048891 Administering mixtures with 6-hydroxy-2,7,8-trimethyl-chroman-2-propanoic acid for treatment of cardiovascular and kidney disorders |
| 04/11/2000 | US6048880 Therapy for cytokine sensitive diseases |
| 04/11/2000 | US6048879 Dietetics |
| 04/11/2000 | US6048875 Benzothiophene, benzofuran and indole compounds |
| 04/11/2000 | US6048873 Skin disorders |
| 04/11/2000 | US6048872 Dietetics; antidiabetic agents; cardiovascular disorders; gastrointestinal disorders |
| 04/11/2000 | US6048866 Substituted 2-anilinopryimidines useful as protein kinase inhibitors |
| 04/11/2000 | US6048858 Heteroring containing a sulfonamide group |
| 04/11/2000 | US6048853 Psychological disorders; nervous system disorders |
| 04/11/2000 | US6048852 Bactericides |
| 04/11/2000 | US6048849 Mixture of hormone or hormone inhibitor and sulfur containing compound |
| 04/11/2000 | US6048841 Enzyme inhibitor; antagonist against tumor necrosis factor |
| 04/11/2000 | US6048724 Producing mammalian transfected cell strain which expresses exogenous dna encoding erythropoietin and glucagons; for prevention or treatment of a condition in which insulin production or glucagon function is defective |
| 04/11/2000 | US6048711 Human G-protein coupled receptor polynucleotides |
| 04/11/2000 | US6048553 Aqueous metal bicarbonate solution useful in treating inflammatory, degenerative and viral diseases |
| 04/11/2000 | US6048524 In vivo production and delivery of erythropoietin for gene therapy |
| 04/11/2000 | US6048523 Polyester cyclic compounds, their complexes and bonded bodies |
| 04/11/2000 | CA2016663C Enzyme inhibiting peptide derivatives |
| 04/11/2000 | CA2016656C Enzyme inhibitors |
| 04/11/2000 | CA2007261C Novel tetralin derivatives |
| 04/11/2000 | CA1340955C Stilbene derivatives |
| 04/08/2000 | CA2285120A1 Heterocycles |
| 04/06/2000 | WO2000019200A1 Identifying agents that alter mitochondrial permeability transition pores |
| 04/06/2000 | WO2000018923A2 Slgp protein and nucleic acid molecule and uses therefor |
| 04/06/2000 | WO2000018918A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 04/06/2000 | WO2000018917A2 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION |
| 04/06/2000 | WO2000018915A2 Membrane-associated organizational proteins |
| 04/06/2000 | WO2000018908A1 Use of specific hybrid promoters for controlling tissue expression |